SAN ANTONIO, June 2 /PRNewswire/ -- BME (BioMedical Enterprises, Inc.), a privately held medical device company and leader in orthopaedic shape memory implant technology, today announced the launch of the OSSAnchor(TM) Grip, a nitinol implant designed to approximate soft tissue to bone.
The Grip is the first in the family of OSSAnchor(TM) nitinol soft tissue implants, designed to secure soft tissue to bone. The Grip is a nitinol implant with aggressive barbs on the legs for bone adhesion, and teeth on the underside of the implant for grasping of soft tissue. The Grip is ideal for upper and lower extremity soft tissue procedures, such as the Achilles tendon reattachment, anterior cruciate ligament reconstruction, and biceps tenodesis.
Made of nitinol, a biocompatible alloy possessing shape memory and super- elastic properties, the OSSAnchor(TM) Grip implant is inserted at room temperature. Using BME’s patented OSSforce(TM) Implant Controller, the implant is safely heated above body temperature. During this process, the implant’s legs change shape to anchor into bone. In addition, the movement of the legs pulls the bridge of the staple down onto the tendon securing it against bone. After heating, the nitinol structure transforms into a state approximately 20% stronger than 316L stainless steel. Due to nitinol’s unique properties, the implant continues to maintain an anchoring compressive force in bone over time.
The OSSAnchor(TM) Grip is also the first orthopaedic nitinol implant to feature barbs for improved pull-out resistance, a new surface treatment that minimizes nickel release, and a roughened surface texture for bone in-growth.
The OSSAnchor(TM) Grip implant was showcased by BME at the Texas Orthopaedic Association’s Annual Meeting held May 22-24, in San Antonio, Texas. A national launch will take place at the American Orthopaedic Foot and Ankle Society summer meeting in Denver, Colorado being held June 25-28.
BME is a medical device company that addresses the changing needs in musculoskeletal medicine. BME focuses on minimally invasive orthopaedic instrumentation and implants that elicit a biologic response. BME’s focus on memory metal internal fixation implants is changing the shape of orthopaedic medicine. Its specialized history of musculoskeletal research services will continue to produce unique, state of the art orthopaedic products that provide better outcomes for patients and more convenience to surgeons. For more information visit http://www.bme-tx.com.
CONTACT: Eric Marcano, Marketing Manager of BioMedical Enterprises, Inc.
[BME], 1-800-880-6528, Fax, 1-866-913-3977
Web site: http://www.bme-tx.com/
